References
- Harrison, J.; VanDolah, B. A.; Brent, A.; Bauer, M. D.; Karen, F.; Mauck, M. D. Clinicians’ Guide to Cannabidiol and Hemp Oils. Mayo Clin. Proc. 2019, 94, 1840–1851. DOI: 10.1016/j.mayocp.2019.01.003.
- Kaplan, B. L. F.; Springs, A. E.; Kaminski, N. E.; Springs, A. E. B.; Kaminski, N. E. The Profile of Immune Modulation by Cannabidiol (CBD) Involves Deregulation of Nuclear Factor of Activated T Cells (NFAT). Biochem Pharmacol. 2008, 76, 726–737. DOI: 10.1016/j.bcp.2008.06.022.
- Nicholas, J. M.; Kaplan, B. L. F. Immune Responses Regulated by Cannabidiol. Cannabis Cannabinoid Res. 2020, 5, 12–31. DOI: 10.1089/can.2018.0073.
- FDA Approves New Indication for Drug Containing an Active Ingredient Derived from Cannabis to Treat Seizures in Rare Genetic Disease. https://www.fda.gov/news-events/press-announcements/fda-approves-new-indication-drug-containing-active-ingredient-derived-cannabis-treat-seizuresrare#:~:text=Epidiolex%20was%20previously%20approved%20for,drug%20substance%20derived%20from%20cannabis 2019 (accessed Aug 23, 2020.
- Abbracchio, M. P.; Ceruti, S.; Colombo, A.; Massi, P.; Parolaro, D.; Vaccani, A. Antitumor Effects of Cannabidiol, a Nonpsychoactive Cannabinoid, on Human Glioma Cell Lines. Journal of Pharmacol. Exp. Therap. 2004, 308, 838–845. DOI: 10.1124/jpet.103.061002.
- McAllister, S. D.; Soroceanu, L.; Desprez, P. The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids. J. Neuroimmun. Pharmacol. 2015, 255–267. DOI: 10.1007/s11481-015-9608-y.
- National Cancer Institute. Cannabis and Cannabinoids (PDQⓇ)- Health Professional Version. National Cancer Institute. https://www.cancer.gov/about-cancer/treatment/cam/hp/cannabis-pdq 2020 (acccessed Aug 23, 2020).
- Baek, S. H.; ChoiPark, W. H. D.; Chu, J. P.; Kang, M. H.; Mi, Y. J. Cannabidiol Induces Cytotoxicity and Cell Death via Apoptotic Pathway in Cancer Cell Lines. Biomol. & Therapeut 2008, 16, 87–94. DOI: 10.4062/biomolther.2008.16.2.087.
- Bronte, V.; Pittet, M. J. The Spleen in Local and Systemic Regulation of Immunity. Immunity. 2013, 39, 806–818. DOI: 10.1016/j.immuni.2013.10.010.
- Ottenweller, J.; Putt, K.; Blumenthal, E. J.; Dhawale, S.; Dhawale, S. W. Inhibition of Prostate Cancer-Cell Proliferation by Essiac. J. Alt. Compl. Med. 2004, 10, 687–691. DOI: 10.1089/acm.2004.10.687.
- Frazier, W. A.; Kosfeld, M. D. Identification of Active Peptide Sequences in the Carboxyl-terminal Cell Binding Domain of Human Thrombospondin-1. J. Biol. Chem. 1992, 267, 16230–16236. https://www.jbc.org/content/267/23/16230.short.
- Armstrong, J. L.; Hill, D. S.; McKee, C. S.; Hernandez-Tiedra, S.; Lorente, M.; Lopez-Valero, I.; Anagnostou, M. E.; Babatunde, F.; Corazzari, M.; Redfern, C. P. F.; et al. Exploding Cannabinoid-Induced Cytotoxic Autophagy to Drive Melanoma Cell Death. J. Invest. Dermatol. 2015, 1629–1637. DOI: 10.1038/jid.2015.45.